Clinical trial
Comparative, Prospective, Single-blinded, Randomized, Multi-Center Clinical Trial to Determine the Performance and Safety of a New Device Injectable Micro-filler Solution Based on Hyaluronic Acid M-HA®30 Architect on the Skin Quality of the Face, Neck and décolleté and Comparing to a Reference Product, Profhilo® on the Lower Part of the Face and Neck: HEBE 8 Study
NCT07007351 is registered in ClinicalTrials.gov with Laboratoires FILLMED as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative, Prospective, Single-blinded, Randomized, Multi-Center Clinical Trial to Determine the Performance and Safety of a New Device Injectable Micro-filler Solution Based on Hyaluronic Acid M-HA®30 Architect on the Skin Quality of the Face, Neck and décolleté and Comparing to a Reference Product, Profhilo® on the Lower Part of the Face and Neck: HEBE 8 Study
- Lead sponsor
- Laboratoires FILLMED
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 19, 2023
- Completion date
- June 13, 2024
- Enrollment
- 285 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
skin aging